TRADJENTA (linagliptin) Patient Assistance Program
Don’t let the high cost of brand DPP-4 inhibitor disrupt your diabetes care. We help eligible patients access Tradjenta (linagliptin) for as little as $69.95 per month through the manufacturer’s Patient Assistance Program.
- Clear & Transparent Pricing
- Paperwork & Doctor-Coordination
- Comprehensive Support: From Application to Entire Journey.
- Annual Re-certification And Refills Management
HIPAA Compliant
BBB Accredited
Secure Website
Key Takeaways:
- Tradjenta (linagliptin) is FDA-approved as adjunct to diet and exercise for type 2 diabetes glycemic control. Once-daily DPP-4 inhibitor — no renal dose adjustment needed.
- Without assistance, Tradjenta costs commonly run approximately $500–$700 per 30-day supply.
- Through AffordMyPrescriptions, qualifying patients can access Tradjenta for a flat $69.95 per month.
- No generic linagliptin currently. Generic sitagliptin (Januvia generic, available 2022) — dramatically cheaper DPP-4 inhibitor alternative. Other generic DPP-4: alogliptin (Nesina generic), saxagliptin (Onglyza generic). SGLT2 inhibitors and GLP-1 RAs generally preferred over DPP-4 in current guidelines due to cardiovascular/renal benefits.
What Is Tradjenta Prescription Assistance Program?
Tradjenta PAP for T2DM patients.
Eligibility verification.
AffordMyPrescriptions eliminates that burden. $69.95/month advocacy.
Pharmacy Price Comparison
- Tradjenta $500–$700/month. Generic sitagliptin much cheaper:
| Pharmacy(With Coupon) | PrIce (30-Day)* | You Save W/ Us |
|---|---|---|
| Walgreens | ~$680 | Save ~$610/mo |
| CVS Pharmacy | ~$700 | Save ~$630/mo |
| Walmart | ~$540 | Save ~$470/mo |
| Costco | ~$520 | Save ~$450/mo |
Generic sitagliptin | ~$40 | Generic DPP-4 alt |
*Just a heads-up — retail prices are estimates based on public data and vary by pharmacy. AffordMyPrescriptions Advocacy Service bypasses this by using drug manufacturer programs to secure your medication directly at no cost or retail price.
Our Pricing:
$69.95 Per month
1 Medications
$79.95 Per Month
2 Medications
$89.95 Per Month
3 Medications
$99.95 Per Month
4+ Medications
Why choose us For Your Tradjenta Prescription Program?
Generic sitagliptin dramatically cheaper DPP-4 alternative. SGLT2/GLP-1 RA generally preferred per guidelines.
Enroll
Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.
We Advocate
Our specialists help gather documentation, complete applications, and coordinate with program providers.
Receive Medication
Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.
Discount Coupons vs. Patient Assistance Programs
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Tradjenta:
Limitations of Coupons
- Prices fluctuate — savings aren’t guaranteed month-to-month
- Copay accumulators may prevent savings from counting toward deductible
- Coupon cards expire and require constant renewal
Still $500–$700 per month even with the best discount
- Can’t be used with Medicare, Medicaid, or government insurance
Advantages of PAP Through Us
- Fixed $69.95/month — never changes regardless of retail price
- No expiration — continuous access as long as you qualify
- Medication supplied directly through the assistance program
- We manage all paperwork, refills, and annual renewals
- If denied, we explore alternative savings on your behalf
DO YOU QUALIFY?
Eligibility is generally determined by annual household income and insurance status. Most programs follow guidelines that include limits of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary by program and household, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for Tradjenta assistance.
- You Are A U.S. Citizen Or Legal Resident
- You Have A Valid Tradjenta Prescription From A Licensed U.S. Healthcare Provider
- You Are Uninsured Or Underinsured And Cannot Afford Your Medication
- You Have Recently Experienced A Change In Financial Circumstances That Affects Your Ability To Pay
Not sure if you qualify? Our pre-qualification check is completely free. If we can’t help, you won’t be charged.
Understanding Tradjenta:
Tradjenta is once-daily oral DPP-4 inhibitor — modest A1c reduction (~0.5–0.8%), weight-neutral, low hypoglycemia risk. Linagliptin’s main practical advantage: no renal dose adjustment (unlike sitagliptin, saxagliptin, alogliptin).
How Tradjenta Works:
GLP-1 and GIP incretin hormones augment glucose-stimulated insulin secretion. DPP-4 enzyme rapidly inactivates incretins. DPP-4 inhibition prolongs incretin activity.
Modest glycemic effect. CV-neutral (no benefit or harm in CV outcome trials). SGLT2 inhibitors (Jardiance, Farxiga) and GLP-1 RAs (Ozempic, Mounjaro) have CV/renal benefits beyond glycemia — generally preferred in current ADA/EASD guidelines.
Form and use:
Tradjenta 5 mg once daily by mouth, with or without food.
Generic availability:
No generic Tradjenta. Other DPP-4: generic sitagliptin (Januvia generic since 2022 — cheapest), generic alogliptin (Nesina generic), generic saxagliptin (Onglyza generic). Sitagliptin most evidence and cheapest. Combination products: Jentadueto (linagliptin/metformin), Glyxambi (empagliflozin/linagliptin), Trijardy XR (empagliflozin/linagliptin/metformin).
Warnings:
Pancreatitis (rare), severe joint pain, bullous pemphigoid (rare), hypoglycemia when combined with sulfonylureas/insulin (otherwise low risk).
FAQ (Frequently Asked Questions)
Cost?
Brand $500–$700/month. Generic sitagliptin $30–$50/month.
Linagliptin advantage?
No renal dose adjustment (unlike other DPP-4s). Useful in CKD or unclear renal function. Otherwise generic sitagliptin much cheaper alternative.
Should I use SGLT2 or GLP-1 RA instead?
Generally yes per current guidelines if appropriate. SGLT2 (Jardiance, Farxiga) reduce CV events, HF, CKD progression. GLP-1 RA (Ozempic, Mounjaro) reduce CV events and promote weight loss. DPP-4 inhibitors CV-neutral — less preferred for most T2DM with CVD/HF/CKD.
Pancreatitis?
Rare but possible — discontinue if pancreatitis suspected. Class effect with DPP-4 inhibitors and GLP-1 RAs.
Denied?
Generic sitagliptin much cheaper. SGLT2/GLP-1 RA alternatives with own PAPs.
Take Control of Your Medication Costs
Generic sitagliptin much cheaper DPP-4 alternative. SGLT2/GLP-1 RA preferred per guidelines. Check eligibility today.
Submit Enrollment Form
Start free by filling out a simple online form.
Receive Welcome Call
Our specialist will contact you for a quick welcome call.
We Manage The Process
Our team handles everything, so you can focus on your health.